After demerger of pharma business, up to 37% upside seen in Piramal Enterprises

The management will now be looking to scale up its loan book, which will entail a consolidation in the wholesale book and strong growth in retail. Even the retail mix will improve, which may translate into a decline in borrowing costs and an upgrade in its credit rating, said Motilal Oswal.

More To Explore

Multibaggers, mirages and market math

An experiment demonstrates how survivorship bias can create the illusion of market genius. By selectively sharing successful predictions and discarding failures, a perfect track record

May 16, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003